Healthcare Marketing Blogs
01|30|26
Mind + Machine: How 2026 Brands Will Win the Future of Pharma Marketing
In our recent webinar, leaders across strategy, creative, technology and omnichannel disciplines explored one essential question: How do 2026 brands win in a rapidly transforming healthcare ecosystem?
01|09|26
The Omnichannel Renaissance: What’s Next for Pharma in 2026?
The life sciences industry is entering a new era. In a recent article penned for Med Ad News, Dan Gandor, EVP of Omnichannel Strategy, coined this the “Omnichannel Renaissance.”
12|29|25
AI’s Next Big Move: Why Pharma Marketers Should Pay Attention
Artificial intelligence is changing the way people interact online, and the pace of innovation is accelerating. Just a few years ago, generative AI was a novelty. Today, platforms such as ChatGPT have become essential tools for millions, shaping how information is shared and decisions are made. At EVERSANA INTOUCH, we’re closely monitoring the next phase […]
12|22|25
DHC Monthly: What Pharma Marketers Should Act On for 2026
The Digital Health Coalition’s December newsletter spotlights year‑end trends and predictions for 2026, featuring insights 18 industry leaders including Susan Perlbachs and Dan Gandor. Read the blog to learn about their key perspectives for 2026.
12|18|25
Balancing Global Consistency and Local Nuance in Pharma Brand Strategy
Creating a brand that resonates across markets while maintaining a strong global identity is one of pharma’s most persistent challenges. According to Susan Perlbachs and John Kenny solving this tension requires a shift in how marketers generate insight, make decisions and adapt creative to cultural nuance.
12|08|25
Leading Healthcare Marketing Into a New Era: Looking Ahead to 2026
As 2025 closes, EVERSANA INTOUCH leaders were featured in Med Ad News’ annual Healthcare Agency Roundup. They shared their insights on how trends are shaping the industry both today and tomorrow and noted how healthcare marketing is entering a transformative era driven by trust, technology and authenticity. Read the blog to learn more.
12|04|25
Insights from Frontiers Health: Innovation, Transformation & the Power of Data
At Frontiers Health Conference in Berlin, Ann Cave, President, Full Service Agencies, shared compelling perspectives on how innovation and data-driven strategies are reshaping patient care. Read her takeaways in this blog.
10|02|25
Unpacking the FDA’s Double Standard
In her latest op-ed for MM+M, Susan Perlbachs, Chief Creative Officer, delivers a powerful reflection on the FDA’s recent wave of untitled and warning letters—and the broader implications for how pharma is scrutinized compared to other industries. Read more.
09|25|25
Navigating the FDA’s DTC Crackdown: What Pharma Marketers Need to Know
The FDA’s recent wave of warning letters targeting direct-to-consumer (DTC) pharmaceutical advertising has sent ripples through the industry. While the agency’s actions may not make TV advertising impossible, they do signal a significant tightening of enforcement—particularly around the Clear, Conspicuous, and Neutral (CCN) standard. Read the blog to learn more.
09|17|25
Decoding the Future of Healthcare: What Patients Want from Their Digital Health Experience
What do patients really want from their digital health experiences? At Fierce Pharma Week 2025, industry leaders tackled this question head-on. Dan Gandor, EVP, Head of Omnichannel & Digital Transformation, delivered a compelling vision for the future, one that places patient needs and expectations at the heart of innovation.